MOH, CRM and NRPA take one step towards phase 1 clinical trials in Malaysia

Top Glove ventures

Malaysia’s Ministry of Health (MOH), the National Pharmaceutical Regulatory Agency (NPRA), and Clinical Research Malaysia (CRM) have taken a step towards the development of a complete clinical research ecosystem in the country with the signing of a scholarship agreement for two NRPA regulatory officers.

NPRA regulatory officers Tang Sia Chin and Nur Atiqah Kamal Rodin will receive education sponsorship from CRM to pursue their postgraduate studies at Manchester University in the UK in September 2017.

Upon completion of the one-year course, they will be awarded the Masters in Experimental Cancer Medicine.

During the course, both candidates will work within a leading Phase 1 cancer clinical trial unit and will learn the details of designing and delivering Phase 1 clinical studies as well as understanding the pre-clinical data required before a clinical programme can commence.

The sponsorship takes CRM’s Phase 1 Realization Project (P1RP) to the next level in its effort to develop a clinical research ecosystem in the country that enables the conduct of clinical trials at all phases, particularly in early phase studies.

Malaysia’s involvement in all phases of drug development enables the transfer of knowledge and technologies to Malaysians as many of these trials test cutting-edge treatment and technologies.

Signing on behalf of MOH is Health Secretary-General YBhg. Dato’ Seri Dr. Chen Chaw Min with CRM CEO Dr. Akhmal Yusof and the two NPRA regulatory officers.

The ceremony is witnessed by the Director-General of Health, YBhg.Datuk Dr. Noor Hisham Abdullah; Deputy Director-General of Health (Research & Technical Support), YBhg. Datuk Dr. Shahnaz Murad; Director, Senior Director of Pharmaceutical Services, Dr. Salmahbt Bahri; and Head of Department, Centre of Investigational New Product, NPRA, Dr. Noraida Mohamad Zainoor.

Subscribe to us to receive updates by email

Enter user information